Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
December 8, 2020, 6:03am
A positive update from Sage:
March 9, 2021, 12:44am
Perfect. This really should be getting more traction in my opinion.